Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Mar 15, 2020 10:31am

153 Views

Post# 30809415

RE:Systematic Review of the Therapeutic Efficacy of Bladder-pre

Very encouraging for Theralase in this phase 2 trial as we can clearly see no other company is even close to the results we expect I.e. matching or exceeding PH1 results of 67% or better. Too bad Ph1 results can't be used in systematic review however looking forward we can hope that Theralase will become a model for future companies in the realm of medical research.

Bullboard Posts

Unique Battery Metals opportunity in Quebec